These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24469045)

  • 81. Polycomb repressive complex 2 regulates normal development of the mouse heart.
    He A; Ma Q; Cao J; von Gise A; Zhou P; Xie H; Zhang B; Hsing M; Christodoulou DC; Cahan P; Daley GQ; Kong SW; Orkin SH; Seidman CE; Seidman JG; Pu WT
    Circ Res; 2012 Feb; 110(3):406-15. PubMed ID: 22158708
    [TBL] [Abstract][Full Text] [Related]  

  • 82. EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers.
    Au SL; Wong CC; Lee JM; Wong CM; Ng IO
    PLoS One; 2013; 8(6):e68226. PubMed ID: 23826380
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma.
    Natsume A; Ito M; Katsushima K; Ohka F; Hatanaka A; Shinjo K; Sato S; Takahashi S; Ishikawa Y; Takeuchi I; Shimogawa H; Uesugi M; Okano H; Kim SU; Wakabayashi T; Issa JP; Sekido Y; Kondo Y
    Cancer Res; 2013 Jul; 73(14):4559-70. PubMed ID: 23720055
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Molecular analysis of PRC2 recruitment to DNA in chromatin and its inhibition by RNA.
    Wang X; Paucek RD; Gooding AR; Brown ZZ; Ge EJ; Muir TW; Cech TR
    Nat Struct Mol Biol; 2017 Dec; 24(12):1028-1038. PubMed ID: 29058709
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Role of the polycomb protein EED in the propagation of repressive histone marks.
    Margueron R; Justin N; Ohno K; Sharpe ML; Son J; Drury WJ; Voigt P; Martin SR; Taylor WR; De Marco V; Pirrotta V; Reinberg D; Gamblin SJ
    Nature; 2009 Oct; 461(7265):762-7. PubMed ID: 19767730
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Global histone H3 lysine 27 triple methylation levels are reduced in vessels with advanced atherosclerotic plaques.
    Wierda RJ; Rietveld IM; van Eggermond MC; Belien JA; van Zwet EW; Lindeman JH; van den Elsen PJ
    Life Sci; 2015 May; 129():3-9. PubMed ID: 25445221
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Replicational Dilution of H3K27me3 in Mammalian Cells and the Role of Poised Promoters.
    Jadhav U; Manieri E; Nalapareddy K; Madha S; Chakrabarti S; Wucherpfennig K; Barefoot M; Shivdasani RA
    Mol Cell; 2020 Apr; 78(1):141-151.e5. PubMed ID: 32027840
    [TBL] [Abstract][Full Text] [Related]  

  • 88. PcG proteins, DNA methylation, and gene repression by chromatin looping.
    Tiwari VK; McGarvey KM; Licchesi JD; Ohm JE; Herman JG; Schübeler D; Baylin SB
    PLoS Biol; 2008 Dec; 6(12):2911-27. PubMed ID: 19053175
    [TBL] [Abstract][Full Text] [Related]  

  • 89. H2AK119Ub1 and H3K27Me3 in molecular staging for survival prediction of patients with pancreatic ductal adenocarcinoma.
    Chen S; Chen J; Zhan Q; Zhu Y; Chen H; Deng X; Hou Z; Shen B; Chen Y; Peng C
    Oncotarget; 2014 Nov; 5(21):10421-33. PubMed ID: 25431952
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Dissecting the role of H3K27 acetylation and methylation in PRC2 mediated control of cellular identity.
    Lavarone E; Barbieri CM; Pasini D
    Nat Commun; 2019 Apr; 10(1):1679. PubMed ID: 30976011
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Epigenetic regulation of enhancer of zeste homolog 2 (EZH2) -Yin Yang 1 (YY1) axis in cancer.
    Chandnani N; Gupta I; Thakkar V; Sarkar K
    Pathol Res Pract; 2023 Nov; 251():154885. PubMed ID: 37862922
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27.
    Kirmizis A; Bartley SM; Kuzmichev A; Margueron R; Reinberg D; Green R; Farnham PJ
    Genes Dev; 2004 Jul; 18(13):1592-605. PubMed ID: 15231737
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Repression of E-cadherin by the polycomb group protein EZH2 in cancer.
    Cao Q; Yu J; Dhanasekaran SM; Kim JH; Mani RS; Tomlins SA; Mehra R; Laxman B; Cao X; Yu J; Kleer CG; Varambally S; Chinnaiyan AM
    Oncogene; 2008 Dec; 27(58):7274-84. PubMed ID: 18806826
    [TBL] [Abstract][Full Text] [Related]  

  • 94. EZH2 Inhibition Blocks Multiple Myeloma Cell Growth through Upregulation of Epithelial Tumor Suppressor Genes.
    Hernando H; Gelato KA; Lesche R; Beckmann G; Koehr S; Otto S; Steigemann P; Stresemann C
    Mol Cancer Ther; 2016 Feb; 15(2):287-98. PubMed ID: 26590165
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Enhancer of zeste homolog-2 (EZH2) methyltransferase regulates transgelin/smooth muscle-22α expression in endothelial cells in response to interleukin-1β and transforming growth factor-β2.
    Maleszewska M; Gjaltema RA; Krenning G; Harmsen MC
    Cell Signal; 2015 Aug; 27(8):1589-96. PubMed ID: 25917318
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Distinct epigenetic regulation of tumor suppressor genes in putative cancer stem cells of solid tumors.
    Yasuda H; Soejima K; Watanabe H; Kawada I; Nakachi I; Yoda S; Nakayama S; Satomi R; Ikemura S; Terai H; Sato T; Suzuki S; Matsuzaki Y; Naoki K; Ishizaka A
    Int J Oncol; 2010 Dec; 37(6):1537-46. PubMed ID: 21042723
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Aberrations of EZH2 in cancer.
    Chase A; Cross NC
    Clin Cancer Res; 2011 May; 17(9):2613-8. PubMed ID: 21367748
    [TBL] [Abstract][Full Text] [Related]  

  • 98. H1 histones control the epigenetic landscape by local chromatin compaction.
    Willcockson MA; Healton SE; Weiss CN; Bartholdy BA; Botbol Y; Mishra LN; Sidhwani DS; Wilson TJ; Pinto HB; Maron MI; Skalina KA; Toro LN; Zhao J; Lee CH; Hou H; Yusufova N; Meydan C; Osunsade A; David Y; Cesarman E; Melnick AM; Sidoli S; Garcia BA; Edelmann W; Macian F; Skoultchi AI
    Nature; 2021 Jan; 589(7841):293-298. PubMed ID: 33299182
    [TBL] [Abstract][Full Text] [Related]  

  • 99. EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR.
    Wang C; Liu Z; Woo CW; Li Z; Wang L; Wei JS; Marquez VE; Bates SE; Jin Q; Khan J; Ge K; Thiele CJ
    Cancer Res; 2012 Jan; 72(1):315-24. PubMed ID: 22068036
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Integrative Multi-Omics Analysis of Oncogenic EZH2 Mutants: From Epigenetic Reprogramming to Molecular Signatures.
    Aldana J; Gardner ML; Freitas MA
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.